Brief: LianBio Announces Positive Topline Results From Phase 3 EXPLORER-CN Trial

LianBio

26/04/2023 13:13

April 26 (Reuters) - LianBio  LIAN.O :
    * LIANBIO ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3
EXPLORER-CN TRIAL EVALUATING MAVACAMTEN IN CHINESE PATIENTS
    * LIANBIO - MAVACAMTEN MET PRIMARY ENDPOINT FOR TREATMENT OF
CHINESE PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC
CARDIOMYOPATHY
    * LIANBIO - MAVACAMTEN DEMONSTRATED A SAFETY PROFILE
CONSISTENT
WITH PREVIOUS STUDIES

Source text for Eikon:  ID:nGNX2Sh2hL 
Further company coverage:  LIAN.O 

 ((Reuters.Briefs@thomsonreuters.com;))